GlassScriptPhysician profile
Jennifer M Smith
NPI 1588849350
$5,953.24
in general payments reported to CMS, 2019-2025
45 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $805 · 2022: $1,161 · 2023: $1,767 · 2024: $1,066 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,986.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $852.18 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $733.48 | 2023-2025 | |
| Lilly USA, LLC | $583.91 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $459.77 | 2022-2025 | |
| Glaxosmithkline, LLC. | $381.30 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sumitomo Pharma America, INC. | $348.60 | 2023 | Gemtesa |
| Amgen INC. | $248.59 | 2021-2025 | Repatha, Otezla, Evenity |
| Daiichi Sankyo INC. | $184.82 | 2021-2023 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $179.78 | 2022-2025 | Farxiga, Airsupra, Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $170.87 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $134.68 | 2021-2025 | |
| Hologic Sales and Service, LLC | $129.83 | 2022-2025 | Aptima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.85 | 2022-2024 | Jardiance, Synjardy |
| Janssen Pharmaceuticals, INC | $119.11 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.55 | 2021-2024 | Trintellix |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.